Analysis of postprogression survival of patients with advanced hepatocellular carcinoma treated with sorafenib

被引：0
|
作者：
Wada, Y. [1 ]
Takami, Y. [1 ]
Matsushima, H. [1 ]
Ryu, T. [1 ]
Mikagi, K. [1 ]
Saitsu, H. [1 ]
机构：
[1] Natl Hosp Org, Kyushu Med Ctr, Clin Res Inst, Dept Hepatobiliary Pancreat Surg, Fukuoka, Japan
来源：
JOURNAL OF HEPATOLOGY | 2017年 / 66卷 / 01期
关键词：
D O I：
10.1016/S0168-8278(17)31709-9
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
SAT-103
引用
收藏
页码：S630 / S631
页数：2
相关论文
共 50 条
  • [21] Post-progression survival and progression-free survival in patients with advanced hepatocellular carcinoma treated by sorafenib
    Terashima, Takeshi
    Yamashita, Tatsuya
    Takata, Noboru
    Nakagawa, Hidetoshi
    Toyama, Tadashi
    Arai, Kuniaki
    Kitamura, Kazuya
    Yamashita, Taro
    Sakai, Yoshio
    Mizukoshi, Eishiro
    Honda, Masao
    Kaneko, Shuichi
    HEPATOLOGY RESEARCH, 2016, 46 (07) : 650 - 656
  • [22] The impact of post-progression survival on overall survival of patients with advanced hepatocellular carcinoma treated by sorafenib therapy
    Terashima, Takeshi
    Yamashita, Tatsuya
    Takata, Noboru
    Nakagawa, Hidetoshi
    Arai, Kuniaki
    Kagaya, Takashi
    Mizukoshi, Eishiro
    Honda, Masao
    Kaneko, Shuichi
    HEPATOLOGY, 2013, 58 : 1221A - 1221A
  • [23] Prediction of Survival in Patients with Hepatocellular Carcinoma Treated with Sorafenib by Comprehensive Serum Glycan Analysis
    Nouso, Kazuhiro
    Miyahara, Koji
    Morimoto, Yuuki
    Takeuchi, Yasuto
    Hagihara, Hiroaki
    Kuwaki, Kenji
    Onishi, Hideki
    Ikeda, Fusao
    Miyake, Yasuhiro
    Nakamura, Shinichiro
    Shiraha, Hidenori
    Takaki, Akinobu
    Takaguchi, Koichi
    Sato, Takahisa
    Sato, Shinpei
    Obi, Shuntaro
    Hirose, Kazuko
    Amano, Maho
    Nishimura, Shin-Ichiro
    Yamamoto, Kazuhide
    HEPATOLOGY, 2013, 58 : 1242A - 1242A
  • [24] Predictor factor of survival in advanced hepatocellular carcinoma treated with sorafenib ∼a multicenter study∼
    Ogawa, Chikara
    Morita, Masahiro
    Omura, Akina
    Shibatoge, Mitsushige
    Tsutsui, Akemi
    Senoh, Tomonori
    Nagano, Takuya
    Takaguchi, Kouichi
    Tani, Joji
    Morishita, Asahiro
    Yoneyama, Hirohito
    Masaki, Tsutomu
    Moriya, Akio
    Ando, Masaharu
    Deguchi, Akihiro
    Kudo, Masatoshi
    ANNALS OF ONCOLOGY, 2018, 29
  • [25] Analysis of survival factors in patients with intermediate-advanced hepatocellular carcinoma treated with transcatheter arterial chemoembolization combined with sorafenib
    Zheng, J.
    Shao, G.
    Luo, J.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2014, 16 (11): : 1012 - 1017
  • [26] Analysis of survival factors in patients with intermediate-advanced hepatocellular carcinoma treated with transcatheter arterial chemoembolization combined with sorafenib
    J. Zheng
    G. Shao
    J. Luo
    Clinical and Translational Oncology, 2014, 16 : 1012 - 1017
  • [27] Postprogression Survival of Patients With Advanced Hepatocellular Carcinoma: Rationale for Second-Line Trial Design
    Reig, Maria
    Rimola, Jordi
    Torres, Ferran
    Darnell, Anna
    Rodriguez-Lope, Carlos
    Forner, Alejandro
    LLarch, Neus
    Rios, Jose
    Ayuso, Carmen
    Bruix, Jordi
    HEPATOLOGY, 2013, 58 (06) : 2023 - 2031
  • [28] Factors Contributing to the Overall Survival in Patients with Hepatocellular Carcinoma Treated by Sorafenib
    Tsukui, Yuya
    Mochizuki, Hitoshi
    Hoshino, Yuji
    Kawakami, Satoshi
    Kuno, Toru
    Fukasawa, Yoshimitsu
    Iwamoto, Fumihiko
    Hirose, Sumio
    Yoshida, Takashi
    Hosoda, Kenji
    Suzuki, Youji
    Hosoda, Kazuhiko
    Kojima, Yuichiro
    Hirose, Yuichi
    Shindou, Kuniaki
    Matsuda, Masanori
    Yagawa, Syoji
    Tawara, Akio
    Kobayashi, Masashi
    Konishi, Toshiyuki
    Yamazaki, Takahisa
    Takahashi, Seiichiro
    Fujii, Hideki
    Enomoto, Nobuyuki
    Omata, Masao
    HEPATO-GASTROENTEROLOGY, 2012, 59 (120) : 2536 - 2539
  • [29] Tolerance and outcomes of sorafenib in elderly patients treated for advanced hepatocellular carcinoma
    Williet, Nicolas
    Clavel, Lea
    Bourmaud, Aurelie
    Verot, Celine
    Bouarioua, Nadia
    Roblin, Xavier
    Merle, Philippe
    Phelip, Jean-Marc
    DIGESTIVE AND LIVER DISEASE, 2017, 49 (09) : 1043 - 1049
  • [30] Predictors of survival in patients with established cirrhosis and hepatocellular carcinoma treated with sorafenib
    Inghilesi, Andrea L.
    Gallori, Donatella
    Antonuzzo, Lorenzo
    Forte, Paolo
    Tomcikova, Daniela
    Arena, Umberto
    Colagrande, Stefano
    Pradella, Silvia
    Fani, Bernardo
    Gianni, Elena
    Boni, Luca
    Laffi, Giacomo
    Di Costanzo, Francesco
    Marra, Fabio
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (03) : 786 - 794
12345